Simplex Trading
PEAR

Simplex Trading’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Simplex Trading’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30
Closed -$4 – 10437
2023
Q1 		$0 Sell
30
-221
-88% -$200 ﹤0.01% 10602
2022
Q4 		$0 Sell
251
-30
-11% -$63 ﹤0.01% 10924
2022
Q3 		$0 Buy
+281
New +$477 ﹤0.01% 11291

Simplex Trading's PEAR Position: Q2 2023 in Review

Simplex Trading sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 30 shares — an estimated $4 sold.

Simplex Trading first reported a position in PEAR in Q3 2022 and held it in 3 quarters. The position peaked at $0 in Q1 2023. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

  • Simplex Trading reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 30 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $4.
  • Simplex Trading first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2022 and held it in 3 quarters.
  • Simplex Trading's Pear Therapeutics, Inc. Class A Common Stock position peaked at $0 in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.